The most valuable minutes in a therapy session are the ones spent listening, not typing. Yet for psychiatrists and therapists, the administrative burden of clinical documentation can consume as much as an hour for every hour of patient care, a drain on both practitioner bandwidth and clinical focus. Nextvisit AI, a New York-based startup founded in 2021, is betting that an AI scribe built specifically for the nuances of behavioral health can reclaim some of that time.
Its platform listens to patient visits and automatically drafts structured clinical notes, including SOAP (Subjective, Objective, Assessment, Plan) notes and intake documentation, aiming to streamline a workflow that is both legally necessary and notoriously burdensome [Nextvisit AI project page]. The company’s early traction, reported at 68 paying customers and $9,000 in monthly recurring revenue as of February 2026, suggests a receptive audience among independent practices and clinicians [This Week in Startups episode, February 2026]. For co-founder and practicing psychiatrist Dr. Faisal Rafiq, the product is an attempt to solve a problem he lives daily.
A Wedge in Mental Health Terminology
Nextvisit AI is not a general-purpose medical transcription service. Its stated differentiation is a deep specialization in the language and workflows of mental health care. Where a generic scribe might stumble over terms like “affect,” “flight of ideas,” or “suicidal ideation,” Nextvisit’s models are trained to recognize and correctly contextualize them within standard psychiatric documentation formats [Nextvisit AI project page]. The platform also integrates with practice management systems common in behavioral health, including Osmind, SimplePractice, and Kalix, aiming to fit into existing clinician routines rather than demanding a wholesale workflow change [Nextvisit AI website].
This focus on a vertical slice of medicine is a common strategy for AI clinical tools, where domain-specific accuracy is non-negotiable. A mistake in a surgical note is catastrophic, but so is mischaracterizing a patient's mental state or treatment plan. Nextvisit’s bet is that by narrowing its scope, it can achieve a level of reliability and utility that broader tools cannot, at least for its core audience of psychiatrists and therapists.
The Founder-Operator Dynamic
The company’s leadership reflects its specialized mission. Dr. Faisal Rafiq serves as CEO, bringing the frontline clinical perspective [Access Newswire, May 2026]. Co-founder and CTO Ryan Yannelli, described as a health-technology engineer, provides the technical build [Ryan Yannelli biography]. This operator-technologist pairing is designed to bridge the gap between clinical need and software execution. The team graduated from Jason Calacanis’s LAUNCH Accelerator in 2026, which included a pitch to Sequoia Capital’s Roelof Botha, and subsequently raised a $200,000 pre-seed round from the LAUNCH Fund [Access Newswire, May 2026] [Startuply.vc, May 2026].
| Co-Founder | Role | Key Background |
|---|---|---|
| Dr. Faisal Rafiq | CEO | Practicing Psychiatrist [Access Newswire, May 2026] |
| Ryan Yannelli | CTO | Health-Technology Engineer [Ryan Yannelli biography] |
Traction and the Path to Scale
The company’s publicly reported metrics, while early, outline a lean initial growth model. In February 2026, Nextvisit AI reported 311 total users, 68 of whom were paying customers, generating $9,000 in MRR [This Week in Startups episode, February 2026]. The company also reported a customer acquisition cost of $189 and a customer lifetime value of $1,700, figures that, if sustained, would suggest a efficient path to profitability for its SaaS model [This Week in Startups episode, February 2026]. The product is offered in two tiers: the core platform for prescribing providers and “Nextvisit Go,” a separate note workspace tailored for non-prescribing therapists and counselors [Nextvisit AI website].
| Metric | Value |
|---|---|
| Paying Customers (Feb 2026) | 68 count |
| Monthly Recurring Revenue (Feb 2026) | 9 K USD |
| Reported Customer Acquisition Cost | 189 USD |
| Reported Customer Lifetime Value | 1700 USD |
Navigating a Crowded and Cautious Field
The ambition is clear, but the path is lined with credible challenges. Nextvisit AI operates in a competitive space with well-funded players like Abridge Inc. and Tandem Health also automating clinical documentation. Its current focus on smaller behavioral health practices is a sensible wedge, but scaling into larger group practices or health systems would require navigating more complex procurement, stricter security audits, and demonstrating efficacy through published clinical validation, which the company has not yet produced.
Furthermore, the regulatory environment for AI in clinical settings is evolving. The U.S. Food and Drug Administration (FDA) has issued guidance on AI-powered clinical decision support software, and while a pure documentation aid may not currently require clearance, any suggestion that the tool aids in diagnosis or treatment planning could attract regulatory scrutiny. For now, Nextvisit appears positioned as a time-saving assistant, a category with a lower immediate barrier but also a need to continually prove its value is more than marginal.
The company’s most plausible answer to these pressures is its founding insight: depth over breadth. By continuing to hone its model on behavioral health conversations and expanding integrations within that ecosystem, it can build a defensible niche. The recent addition of features like a “cross-titration advisor” for medication management and a telehealth beta request signal a roadmap focused on deepening utility for its core users, not chasing general medical applications [Nextvisit news page, August 2026].
The Standard of Care Today
The patient population here is dual: the clinicians treating conditions like major depressive disorder, generalized anxiety, and PTSD, and the patients themselves who benefit from more focused care. For these providers, the current standard of care for documentation is largely manual. It involves typing notes during or after a session, often relying on memory or scattered handwritten points, a process that extends the workday and contributes to burnout. Tools like generic voice-to-text or electronic health record templates offer limited relief, as they lack the specialized structuring and coding required for mental health. Nextvisit AI is attempting to insert itself into this gap, not by replacing clinical judgment, but by handling the administrative translation of that judgment into the required record.
The next twelve months will be a test of whether this specialized approach can convert early adoption into durable growth. Key milestones will likely include a seed round to accelerate hiring and product development, the formal launch of its telehealth integration, and the pursuit of partnerships with larger behavioral health networks. For a field where the human conversation is the primary intervention, a tool that faithfully captures its content could prove to be more than a convenience. It could become a foundational piece of the modern therapeutic practice.
Sources
- [Nextvisit AI project page] Nextvisit AI project page | https://ryanyannelli.com/projects/nextvisit-ai/
- [This Week in Startups episode, February 2026] We built OpenClaw Ultron to replace 20 people at our company | https://pod.wave.co/podcast/this-week-in-startups/we-built-openclaw-ultron-to-replace-20-people-at-our-company-e2246
- [Nextvisit AI website] Nextvisit AI website | https://nextvisit.ai
- [Access Newswire, May 2026] Nextvisit AI Graduates from Jason Calacanis' LAUNCH Accelerator | https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/nextvisit-ai-graduates-from-jason-calacanis-launch-accelerator-advanc-1119859
- [Ryan Yannelli biography] Ryan Yannelli biography | https://ryanyannelli.com/about/
- [Startuply.vc, May 2026] Nextvisit AI's $9,000 MRR Anchors a Bet on the Therapist's Scribe | https://startuply.vc/article/nextvisit-ai-s-9-000-mrr-anchors-a-bet-on-the-therapist-s-scribe-14dieg
- [Nextvisit news page, August 2026] Nextvisit news page | https://nextvisit.ai/news